by Tibor Bajnovič
Kaing Guek Eav alias Duch, a former chairman of the S-21 Security Centre, is scheduled to testify in Case 002/02 from 26 May 2016. He is called to testify on the topic of Security Centres and Internal Purges, in particular S-21 Security Centre. Duch first appeared as a witness in Case 002/01 in March and April 2012.
Duch was the first Khmer Rouge official to stand on trial before the ECCC in Case 001. On 26 July 2010, the Trial Chamber convicted Duch of crimes against humanity and grave breaches of the 1949 Geneva Conventions for his role at the S-21 Security Centre. In that role he oversaw the torture and execution of at least 12,272 individuals. Duch was sentenced to 35 years imprisonment, with a reduction of five years as a remedy for his eight-year unlawful detention by Cambodian Military Court. The sentence caused a widespread public dissatisfaction in Cambodia.
On 3 February 2012, the Supreme Court Chamber — the ECCC’s final court of appeal — overturned the sentence imposed on Duch at trial, increasing it to life imprisonment. The Supreme Court Chamber also refused to provide a remedy for Duch’s eight-year illegal detention on the ground that the ECCC was not responsible for the violation. From a human rights and fair trial perspective, the Supreme Court Chamber’s treatment of Duch’s eight-year illegal detention raised significant concerns.
The Case 002 has been severed into two separate trials, each addressing a different section of the indictment. The trial judgement in Case 002/01 was pronounced on 7 August 2014. Nuon Chea and Khieu Samphan were both found guilty of crimes against humanity and sentenced to life imprisonment. Following the appeals filed by both Accused, the appeal hearings in Case 002/01 commenced on 2 July 2015 and were closed by the President of the Supreme Court Chamber on 18 February 2016.
The trial hearings in Case 002/02 commenced on 17 October 2014 and are ongoing. It is expected that evidentiary hearings in Case 002/02 will conclude later this year, with a judgement to follow in 2017.